These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 1284041)
21. Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma. Fitoussi O; Simon D; Brice P; Makke J; Scrobohaci ML; Bibi Triki T; Hennequin C; Fermé C; Gisselbrecht C Bone Marrow Transplant; 1999 Oct; 24(7):747-55. PubMed ID: 10516678 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226 [TBL] [Abstract][Full Text] [Related]
23. Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survival. Coiffier B; Bryon PA; Ffrench M; Blanc M; Sebban C; Berger F; Viala JJ Blood; 1987 Nov; 70(5):1394-9. PubMed ID: 2444287 [TBL] [Abstract][Full Text] [Related]
24. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. Coiffier B; Gisselbrecht C; Herbrecht R; Tilly H; Bosly A; Brousse N J Clin Oncol; 1989 Aug; 7(8):1018-26. PubMed ID: 2474057 [TBL] [Abstract][Full Text] [Related]
26. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172 [TBL] [Abstract][Full Text] [Related]
27. Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen. Herbrecht R; Ortiz S; Damonte JC; Liu KL; Maloisel F; Dufour P; Bergerat JP; Oberling F Hematol Oncol; 1991; 9(4-5):253-7. PubMed ID: 1720760 [TBL] [Abstract][Full Text] [Related]
28. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. André M; Mounier N; Leleu X; Sonet A; Brice P; Henry-Amar M; Tilly H; Coiffier B; Bosly A; Morel P; Haioun C; Gaulard P; Reyes F; Gisselbrecht C; Blood; 2004 Feb; 103(4):1222-8. PubMed ID: 14576060 [TBL] [Abstract][Full Text] [Related]
29. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Salles G; Herbrecht R; Tilly H; Berger F; Brousse N; Gisselbrecht C; Coiffier B Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. Bosly A; Coiffier B; Gisselbrecht C; Tilly H; Auzanneau G; Andrien F; Herbrecht R; Legros M; Devaux Y; Jaubert J J Clin Oncol; 1992 Oct; 10(10):1615-23. PubMed ID: 1383435 [TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy. Heinz R Blut; 1990 Feb; 60(2):68-75. PubMed ID: 2302465 [TBL] [Abstract][Full Text] [Related]
33. Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy. Salloum E; Henry-Amar M; Caillou B; Friedman S; Pico JL; Bayle C; Hayat M Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1609-16. PubMed ID: 3208805 [TBL] [Abstract][Full Text] [Related]
34. [Malignant lymphoma--recent progress in diagnosis and treatment. (Supplement 1). Long-term survivors of malignant lymphoma patients treated with combination chemotherapy: retrospective analysis]. Kimura I Nihon Naika Gakkai Zasshi; 1983 Oct; 72(10):1342-4. PubMed ID: 6676406 [No Abstract] [Full Text] [Related]
35. Lymphoblastic lymphoma: late relapse in childhood. Levine PL; Berberich FR; Burke JS; Mott MG; Wilbur JR Med Pediatr Oncol; 1983; 11(1):33-6. PubMed ID: 6687624 [TBL] [Abstract][Full Text] [Related]
36. Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen. Coiffier B; Lepage E Blood; 1989 Aug; 74(2):558-64. PubMed ID: 2752133 [TBL] [Abstract][Full Text] [Related]
37. Trauma as an etiologic factor of primary bone lymphoma: a report of 4 cases. Stein ME; Lewis DC; Gershuny AR; Quigley MM; Zaidan J; Danieli NS; Whelan J; Subramanian R J BUON; 2003; 8(2):163-6. PubMed ID: 17472245 [TBL] [Abstract][Full Text] [Related]
38. Modified order of allelic replication in lymphoma patients at different disease stages. Amiel A; Elis A; Blumenthal D; Gaber E; Fejgin MD; Dubinsky R; Lishner M Cancer Genet Cytogenet; 2001 Mar; 125(2):156-60. PubMed ID: 11369060 [TBL] [Abstract][Full Text] [Related]
39. Immunosuppressant-Responsive Enteropathy and Non-Responsive Enteropathy in Dogs: Prognostic Factors, Short- and Long-Term Follow Up. Benvenuti E; Pierini A; Bottero E; Pietra M; Gori E; Salvadori S; Marchetti V Animals (Basel); 2021 Sep; 11(9):. PubMed ID: 34573603 [TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol]. Dumontet C; Bastion Y; Felman P; Ffrench M; Blanc M; Peaud PY; Bryon PA; Coiffier B Bull Cancer; 1992; 79(10):979-89. PubMed ID: 1284041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]